Cargando…

Spot Weight Adaptation for Moving Target in Spot Scanning Proton Therapy

PURPOSE: This study describes a real-time spot weight adaptation method in spot-scanning proton therapy for moving target or moving patient, so that the resultant dose distribution closely matches the planned dose distribution. MATERIALS AND METHODS: The method proposed in this study adapts the weig...

Descripción completa

Detalles Bibliográficos
Autores principales: Morel, Paul, Wu, Xiaodong, Blin, Guillaume, Vialette, Stéphane, Flynn, Ryan, Hyer, Daniel, Wang, Dongxu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447005/
https://www.ncbi.nlm.nih.gov/pubmed/26075184
http://dx.doi.org/10.3389/fonc.2015.00119
_version_ 1782373533630857216
author Morel, Paul
Wu, Xiaodong
Blin, Guillaume
Vialette, Stéphane
Flynn, Ryan
Hyer, Daniel
Wang, Dongxu
author_facet Morel, Paul
Wu, Xiaodong
Blin, Guillaume
Vialette, Stéphane
Flynn, Ryan
Hyer, Daniel
Wang, Dongxu
author_sort Morel, Paul
collection PubMed
description PURPOSE: This study describes a real-time spot weight adaptation method in spot-scanning proton therapy for moving target or moving patient, so that the resultant dose distribution closely matches the planned dose distribution. MATERIALS AND METHODS: The method proposed in this study adapts the weight (MU) of the delivering pencil beam to that of the target spot; it will actually hit during patient/target motion. The target spot that a certain delivering pencil beam may hit relies on patient monitoring and/or motion modeling using four-dimensional (4D) CT. After the adapted delivery, the required total weight [Monitor Unit (MU)] for this target spot is then subtracted from the planned value. With continuous patient motion and continuous spot scanning, the planned doses to all target spots will eventually be all fulfilled. In a proof-of-principle test, a lung case was presented with realistic temporal and motion parameters; the resultant dose distribution using spot weight adaptation was compared to that without using this method. The impact of the real-time patient/target position tracking or prediction was also investigated. RESULTS: For moderate motion (i.e., mean amplitude 0.5 cm), D95% to the planning target volume (PTV) was only 81.5% of the prescription (R(X)) dose; with spot weight adaptation PTV D95% achieves 97.7% R(X). For large motion amplitude (i.e., 1.5 cm), without spot weight adaptation PTV D95% is only 42.9% of R(X); with spot weight adaptation, PTV D95% achieves 97.7% R(X). Larger errors in patient/target position tracking or prediction led to worse final target coverage; an error of 3 mm or smaller in patient/target position tracking is preferred. CONCLUSION: The proposed spot weight adaptation method was able to deliver the planned dose distribution and maintain target coverage when patient motion was involved. The successful implementation of this method would rely on accurate monitoring or prediction of patient/target motion.
format Online
Article
Text
id pubmed-4447005
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-44470052015-06-12 Spot Weight Adaptation for Moving Target in Spot Scanning Proton Therapy Morel, Paul Wu, Xiaodong Blin, Guillaume Vialette, Stéphane Flynn, Ryan Hyer, Daniel Wang, Dongxu Front Oncol Oncology PURPOSE: This study describes a real-time spot weight adaptation method in spot-scanning proton therapy for moving target or moving patient, so that the resultant dose distribution closely matches the planned dose distribution. MATERIALS AND METHODS: The method proposed in this study adapts the weight (MU) of the delivering pencil beam to that of the target spot; it will actually hit during patient/target motion. The target spot that a certain delivering pencil beam may hit relies on patient monitoring and/or motion modeling using four-dimensional (4D) CT. After the adapted delivery, the required total weight [Monitor Unit (MU)] for this target spot is then subtracted from the planned value. With continuous patient motion and continuous spot scanning, the planned doses to all target spots will eventually be all fulfilled. In a proof-of-principle test, a lung case was presented with realistic temporal and motion parameters; the resultant dose distribution using spot weight adaptation was compared to that without using this method. The impact of the real-time patient/target position tracking or prediction was also investigated. RESULTS: For moderate motion (i.e., mean amplitude 0.5 cm), D95% to the planning target volume (PTV) was only 81.5% of the prescription (R(X)) dose; with spot weight adaptation PTV D95% achieves 97.7% R(X). For large motion amplitude (i.e., 1.5 cm), without spot weight adaptation PTV D95% is only 42.9% of R(X); with spot weight adaptation, PTV D95% achieves 97.7% R(X). Larger errors in patient/target position tracking or prediction led to worse final target coverage; an error of 3 mm or smaller in patient/target position tracking is preferred. CONCLUSION: The proposed spot weight adaptation method was able to deliver the planned dose distribution and maintain target coverage when patient motion was involved. The successful implementation of this method would rely on accurate monitoring or prediction of patient/target motion. Frontiers Media S.A. 2015-05-28 /pmc/articles/PMC4447005/ /pubmed/26075184 http://dx.doi.org/10.3389/fonc.2015.00119 Text en Copyright © 2015 Morel, Wu, Blin, Vialette, Flynn, Hyer and Wang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Morel, Paul
Wu, Xiaodong
Blin, Guillaume
Vialette, Stéphane
Flynn, Ryan
Hyer, Daniel
Wang, Dongxu
Spot Weight Adaptation for Moving Target in Spot Scanning Proton Therapy
title Spot Weight Adaptation for Moving Target in Spot Scanning Proton Therapy
title_full Spot Weight Adaptation for Moving Target in Spot Scanning Proton Therapy
title_fullStr Spot Weight Adaptation for Moving Target in Spot Scanning Proton Therapy
title_full_unstemmed Spot Weight Adaptation for Moving Target in Spot Scanning Proton Therapy
title_short Spot Weight Adaptation for Moving Target in Spot Scanning Proton Therapy
title_sort spot weight adaptation for moving target in spot scanning proton therapy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447005/
https://www.ncbi.nlm.nih.gov/pubmed/26075184
http://dx.doi.org/10.3389/fonc.2015.00119
work_keys_str_mv AT morelpaul spotweightadaptationformovingtargetinspotscanningprotontherapy
AT wuxiaodong spotweightadaptationformovingtargetinspotscanningprotontherapy
AT blinguillaume spotweightadaptationformovingtargetinspotscanningprotontherapy
AT vialettestephane spotweightadaptationformovingtargetinspotscanningprotontherapy
AT flynnryan spotweightadaptationformovingtargetinspotscanningprotontherapy
AT hyerdaniel spotweightadaptationformovingtargetinspotscanningprotontherapy
AT wangdongxu spotweightadaptationformovingtargetinspotscanningprotontherapy